Mefruside

Mefruside
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral
ATC code C03BA05 (WHO)
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 7195-27-9 YesY
PubChem (CID) 4047
ChemSpider 3907 N
UNII X1NS9SNS92 YesY
KEGG D01877 YesY
ECHA InfoCard 100.027.785
Chemical and physical data
Formula C13H19ClN2O5S2
Molar mass 382.88 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.[1]

It was developed by Bayer A.G. and is sold under the tradename Baycaron.

References

  1. ↑ Allen HB, Lee DA (1973). "A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension". Curr Med Res Opin. 1 (9): 547–53. doi:10.1185/03007997309111720. PMID 4779251.


This article is issued from Wikipedia - version of the 5/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.